Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G KETTLE

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Nuclear Medicine Communications|November 1, 1989
99Tcm sestamibi--a new agent for parathyroid imagingA J Coakley, A G Kettle, C P Wells, et al.
Nuclear Medicine Communications|March 27, 1998
The value of the chest radiograph in reporting aerosol ventilation-perfusion scansE R Denton, S F Barrington, A G Kettle, et al.
Expert Opinion on Therapeutic Patents|November 5, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Expert Opinion on Therapeutic Patents|November 8, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
European Journal of Nuclear Medicine|February 1, 1996
Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidS F Barrington, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|December 11, 1997
Pentavalent 99Tcm-DMSA imaging in patients with bone metastasesA S Lam, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|December 1, 1995
Home reporting for the nuclear clinician?M J O'Doherty, A G Kettle, N J Bird, et al.
European Journal of Nuclear Medicine|June 10, 1998
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studiesP J Blower, A S Lam, M J O'Doherty, et al.
European Journal of Nuclear Medicine|June 10, 1998
Therapeutic implications of thymic uptake of radioiodine in thyroid carcinomaL M Wilson, S F Barrington, I D Morrison, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitorsRichard Ducray, Peter Ballard, Bernard C Barlaam, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|November 1, 1989
99Tcm sestamibi--a new agent for parathyroid imagingA J Coakley, A G Kettle, C P Wells, et al.
Nuclear Medicine Communications|March 27, 1998
The value of the chest radiograph in reporting aerosol ventilation-perfusion scansE R Denton, S F Barrington, A G Kettle, et al.
Expert Opinion on Therapeutic Patents|November 5, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Expert Opinion on Therapeutic Patents|November 8, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
European Journal of Nuclear Medicine|February 1, 1996
Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidS F Barrington, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|December 11, 1997
Pentavalent 99Tcm-DMSA imaging in patients with bone metastasesA S Lam, A G Kettle, M J O'Doherty, et al.
Nuclear Medicine Communications|December 1, 1995
Home reporting for the nuclear clinician?M J O'Doherty, A G Kettle, N J Bird, et al.
European Journal of Nuclear Medicine|June 10, 1998
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studiesP J Blower, A S Lam, M J O'Doherty, et al.
European Journal of Nuclear Medicine|June 10, 1998
Therapeutic implications of thymic uptake of radioiodine in thyroid carcinomaL M Wilson, S F Barrington, I D Morrison, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitorsRichard Ducray, Peter Ballard, Bernard C Barlaam, et al.
Pageof 8